BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16051067)

  • 1. Host defense effector molecules in mucosal secretions.
    Tjabringa GS; Vos JB; Olthuis D; Ninaber DK; Rabe KF; Schalkwijk J; Hiemstra PS; Zeeuwen PL
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):151-8. PubMed ID: 16051067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
    Cole AM; Cole AL
    Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins.
    van Wetering S; van der Linden AC; van Sterkenburg MA; de Boer WI; Kuijpers AL; Schalkwijk J; Hiemstra PS
    Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L51-8. PubMed ID: 10645890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLPI and elafin: one glove, many fingers.
    Williams SE; Brown TI; Roghanian A; Sallenave JM
    Clin Sci (Lond); 2006 Jan; 110(1):21-35. PubMed ID: 16336202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neutrophil elastase inhibitors in innate and adaptive immunity.
    Fitch PM; Roghanian A; Howie SE; Sallenave JM
    Biochem Soc Trans; 2006 Apr; 34(Pt 2):279-82. PubMed ID: 16545094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).
    Fritz H
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():79-82. PubMed ID: 3060147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides.
    Zuyderduyn S; Ninaber DK; Schrumpf JA; van Sterkenburg MA; Verhoosel RM; Prins FA; van Wetering S; Rabe KF; Hiemstra PS
    Respir Res; 2011 May; 12(1):59. PubMed ID: 21529380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial antimicrobial peptides in host defense against infection.
    Bals R
    Respir Res; 2000; 1(3):141-50. PubMed ID: 11667978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity.
    Auvynet C; Rosenstein Y
    FEBS J; 2009 Nov; 276(22):6497-508. PubMed ID: 19817855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial peptides: effectors of innate immunity in the skin.
    Barak O; Treat JR; James WD
    Adv Dermatol; 2005; 21():357-74. PubMed ID: 16350450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
    Tjabringa GS; Rabe KF; Hiemstra PS
    Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human defensins and LL-37 in mucosal immunity.
    Doss M; White MR; Tecle T; Hartshorn KL
    J Leukoc Biol; 2010 Jan; 87(1):79-92. PubMed ID: 19808939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection.
    Schaller-Bals S; Schulze A; Bals R
    Am J Respir Crit Care Med; 2002 Apr; 165(7):992-5. PubMed ID: 11934727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial host defense in the upper gastrointestinal tract.
    Hosaka Y; Koslowski M; Nuding S; Wang G; Schlee M; Schäfer C; Saigenji K; Stange EF; Wehkamp J
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1151-8. PubMed ID: 18989140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.
    Romas LM; Hasselrot K; Aboud LG; Birse KD; Ball TB; Broliden K; Burgener AD
    PLoS One; 2014; 9(6):e100820. PubMed ID: 24978053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome.
    Anderson RL; Hiemstra PS; Ward C; Forrest IA; Murphy D; Proud D; Lordan J; Corris PA; Fisher AJ
    Eur Respir J; 2008 Sep; 32(3):670-7. PubMed ID: 18508823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
    Higashimoto Y; Yamagata Y; Iwata T; Ishiguchi T; Okada M; Masuda M; Satoh H; Itoh H
    Respiration; 2005; 72(6):629-35. PubMed ID: 16355004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides.
    Kooi C; Sokol PA
    Microbiology (Reading); 2009 Sep; 155(Pt 9):2818-2825. PubMed ID: 19542010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defence molecules in intestinal innate immunity against bacterial infections.
    Eckmann L
    Curr Opin Gastroenterol; 2005 Mar; 21(2):147-51. PubMed ID: 15711205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.